Purchase Order 75N95022P00140
Award Date 2/23/22
Potential Completion Date 2/22/25
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Kingsville, MD 21087, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
7
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse issued a purchase order to Darryle Schoepp for pharmacology consulting services on February 23, 2022, with a ceiling value of $69,078.40. The order is set aside as a Total Small Business acquisition. Work is performed in Ardmore, Pennsylvania, and covers pharmacology consulting in support of drug discovery and developmental programs and the associated Blueprint Neurotherapeutics Network external oversight committee for NINDS. Pricing is labor-hour based....
- The National Institute on Drug Abuse awarded a purchase order to Shabas Solutions LLC, a Women-Owned Small Business, for biologics subject matter expert consulting services valued at $472,711.24, with an award date of April 15, 2022. The order carries a total small business set-aside. Performance is located in Bethesda, Maryland. The contract provided technical recommendations and advice supporting novel biologics development programs, including expertise across biologics development,...
- This purchase order award from the Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke to Detke Biopharma Consulting LLC is for $70,500 to provide pharmacology consulting services in support of the NIH Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs through February 2025. As a member of the BPN External Oversight Committee, the contractor will provide strategic guidance and technical...
- The National Institute on Drug Abuse awarded a $79,569.86 firm fixed-price purchase order to Salient Science & Technology LLC for pharmaceutical business development consulting services. The contract, designated as a Total Small Business set-aside, was awarded on February 27, 2017, with an ultimate completion date of April 14, 2022. Work is being performed in Bethesda, Maryland, and the engagement focuses on business development consulting support for the institute's pharmaceutical...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
- The National Institute on Drug Abuse awarded a purchase order to Johnson, Graham, a small business sole proprietorship, for medicinal chemistry consulting services on July 26, 2022, with a ceiling value of $437,670 and ultimate completion date of July 26, 2025. The work is performed in Bethesda, Maryland and supports drug discovery initiatives within the NIH Blueprint Neurotherapeutics Network and the NIH Helping to End Addiction Long-term Initiative. The contract is a labor-hour arrangement...
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- The National Institute on Drug Abuse issued a purchase order to Certara USA Inc. for toxicology consulting services supporting NIH neuroscience-focused drug discovery and development programs, with a ceiling value of $2,145,075 and an award date of September 20, 2022. Work is performed in Princeton, New Jersey. The order provides toxicology consulting services to the National Institute of Neurological Disorders and Stroke, the NIH Blueprint Neurotherapeutics Network, the Helping to End Addiction...
- The National Institute on Drug Abuse issued a delivery order to The Bizzell Group LLC, an SBA-certified HUBZone small business, on April 27, 2026, under an 8(a) sole source set-aside with a ceiling value of $94,951.00 for logistics, communications, and clinical study auxiliary support for the Division of Therapeutics and Medical Consequences. The order is priced on a time and materials basis with an ultimate completion date of April 26, 2027. Place of performance is Bowie, Maryland.
- <p>The National Institute on Drug Abuse issued a purchase order to White Global Pharma Consultants LLC valued at $409,583.99 on June 30, 2022, for subject matter expert consulting in drug metabolism pharmacokinetics (DMPK) under the FY26 UDO Initiative. Work is performed in Cranbury, New Jersey. The order carries no set-aside. Ultimate completion is scheduled for June 30, 2025. Pricing is labor-hour based.</p>
The National Institute on Drug Abuse awarded a purchase order to Slusher Barbara for pharmacology consulting services in support of the Blueprint Neurotherapeutics Network (BPN) drug discovery and developmental programs, valued at $49,314.99, with an award date of February 23, 2022. The order carries a Total Small Business set-aside. Work is performed in Kingsville, Maryland. The purchase order covers pharmacology consulting and external oversight committee support for NINDS; pricing is labor-hour based. Ultimate completion was scheduled for February 22, 2025. The solicitation posted January 7, 2022, with a due date of January 14, 2022.
Generated 7/2/26, 2:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($21k) | 5/4/26 | |
| P00002 | Exercise an Option | $11.5k | 2/2/24 | |
| P00001 | Exercise an Option | $11.5k | 3/29/23 | |
| Not listed | Not listed | $10.0k | 2/23/22 |